Regeneration and control of human fibroblast cell density by intermittently delivered pulsed electric fields

Biotechnology and Bioengineering

Volumn 110, Issue 6, 2013, Pages 1759-1768

  Golberg, Alexander ^a   Bei, Marianna ^a,b   Sheridan, Robert L ^c   Yarmush, Martin L ^a,d  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b FORSYTH INSTITUTE   (United States)

^c Shriners Burns Institute   (United States)

^d RUTGERS UNIVERSITY   (United States)

Author keywords

Cell density control; Fibroblasts; Intermittently delivered pulsed electric fields; Irreversible electroporation; Proliferative scarring

Indexed keywords

BIOMATERIALS; CELL CULTURE; CELL DEATH; CELL MEMBRANES; ELECTRIC FIELDS; TISSUE REGENERATION; WEIBULL DISTRIBUTION;

CELL DENSITY CONTROL; CHEMICAL-FREE METHODS; ELECTRIC FIELD STRENGTH; ELECTROPORATION; HUMAN FIBROBLAST CELLS; NORMAL HUMAN DERMAL FIBROBLASTS; PROLIFERATIVE SCARRING; PULSED ELECTRIC FIELD;

FIBROBLASTS;

ARTICLE; CELL DAMAGE; CELL DEATH; CELL DENSITY; CELL GROWTH; CELL MEMBRANE; CELL REGENERATION; CELL SURVIVAL; CELLULAR DISTRIBUTION; FIBROBLAST; HUMAN; HUMAN CELL; PULSED ELECTRIC FIELD; WOUND HEALING;

ANIMALIA;

APOPTOSIS; CELL COUNT; CELL LINE; CELL PROLIFERATION; CELL SURVIVAL; DOSE-RESPONSE RELATIONSHIP, RADIATION; ELECTROPORATION; FIBROBLASTS; HUMANS; REGENERATION;

EID: 84876767313     PISSN: 00063592     EISSN: 10970290     Source Type: Journal    
DOI: 10.1002/bit.24831     Document Type: Article

References (56)

1. Aarabi S, Longaker MT, Gurtner GC. 2007. Hypertrophic scar formation following burns and trauma: New approaches to treatment. PLoS Med 4(9): e234.
2. Barbosa-Canovas GV, Pothakamury UR, Palou E, Swanson BG. 1998. Nonthermal preservation of foods. New York: Marcel Dekker.
3. Border WA, Noble NA. 1994. Transforming growth factor beta in tissue fibrosis. N Engl J Med 331(19): 1286-1292.
4. Chau D, Mancoll JS, Lee S, Zhao J, Phillips LG, Gittes GK, Longaker MT. 1998. Tamoxifen downregulates TGF-[beta] production in keloid fibroblasts. Ann Plast Surg 40(5): 490-493.
5. Corrales M, Toepfl S, Butz P, Knorr D, Tauscher B. 2008. Extraction of anthocyanins from grape by-products assisted by ultrasonics, high hydrostatic pressure or pulsed electric fields: A comparison. Innovative Food Sci Emerg Technol 9(1): 85-91.
6. Cuono CB. 1990. Scars and keloids. In: Jurkiewicz MJ, Mathes SJ, Krizek T, Ariyan S, editors. Plastic surgery: Principles and practice. St Louis: Mosby, MO. p 1411-1428.
7. Desmoulliere A, Redard M, Darby I, Gabbiani G. 1995. Apoptosis mediates the decrease in cellularity during the transition between granulation tissue and scar. Am J Pathol 146: 56-66.
8. Diegelmann RF, Evans MC. 2004. Wound healing: An overview of acute, fibrotic and delayed healing. Front Biosci 9: 283-289.
9. Ding J, Hori K, Zhang R, Marcoux Y, Honardoust D, Shankowsky HA, Tredget EE. 2011. Stromal cell-derived factor 1 (SDF-1) and its receptor CXCR4 in the formation of postburn hypertrophic scar (HTS). Wound Repair Regen 19(5): 568-578.
10. Dubey AK, Gupta SD, Basu B. 2011. Optimization of electrical stimulation parameters for enhanced cell proliferation on biomaterial surfaces. J Biomed Mater Res Part B Appl Biomater 98B(1): 18-29.
11. Garg HG, Longaker MT. 2000. Scarless wound healing. New York: Marcel Dekker. p 333.
12. Golberg A. 2012. Microbial load control by intermittently delivered pulsed electric fields, Proceedings of Bio and Food Electro-Technologies, Solerno, Italy. European Cooperation on Science and Technologies. p 1-6.
13. Golberg A, Rubinsky B. 2010. A statistical model for multidimensional irreversible electroporation cell death in tissue. Biomed Eng Online 9: 1-13.
14. Golberg A, Rubinsky B. 2012. Towards electroporation based treatment planning considering electric field induced muscle contractions. Technol Cancer Res Treat 11: 189-201.
15. Golberg A, Belkin M, Rubinsky B. 2009. Irreversible electroporation for microbial control of drugs in solution. AAPS PharmSciTech 10(3): 881-886.
16. Golberg A, Kandel J, Belkin M, Rubinsky B. 2010. Intermittently delivered pulsed electric fields for sterile storage of turbid media. IEEE Trans Plasma Sci 38(11): 3211-3218.
17. Hu D, Hughes M, Cherry G. 1998. Topical tamoxifen-A potential therapeutic regime in treating excessive dermal scarring? Br J Plast Surg 51: 462-469.
18. Iocono JA, Ehrlich HP, Gottrup F, Leaper DJ. 1998. The biology of healing. In: Leaper DJ, Harding KG, editors. Wounds: biology and management. Oxford, UK: Oxford University Press. p 4-15.
19. 22 in Dupuytren's affected palmar fascia. J Surg Res 103(2): 146-152.
20. Lazarus GS, Cooper DM, Knighton DR, Margolis DJ, Pecoraro RE, Rodeheaver G, Robson MC. 1994. Definitions and guidelines for assessment of wounds and evaluation of healing. Arch Dermatol 130(4): 489-493.
21. Leask A, Abraham DJ. 2004. TGF-beta signaling and the fibrotic response. FASEB J 18(7): 816-827.
22. Lelieved HLM, Notermans S, de Haan SWH. 2007. Food preservation by pulsed electric fields. From research to application. Cambridge, England: CRC. p 363.
23. 21 production by keloid and fetal fibroblasts. Arch Facial Plast Surg 3(2): 111-114.
24. Neumann E, Schaefer-Ridder M, Wang Y, Hofschneider PH. 1982. Gene transfer into mouse lyoma cells by electroporation in high electric fields. EMBO J 1(7): 841-845.
25. Occleston NL, Laverty HG, O'Kane S, Ferguson MWJ. 2008. Prevention and reduction of scarring in the skin by Transforming Growth Factor beta 3 (TGF3): From laboratory discovery to clinical pharmaceutical. J Biomater Sci Polym Edn 19(8): 1047-1063.
26. Ogawa R. 2010. The most current algorithms for the treatment and prevention of hypertrophic scars and keloids. Plast Reconstr Surg 125(2): 557-568.
27. O'Kane S, Ferguson MWJ. 1997. Transforming growth factor beta and wound healing. Int J Biochem Cell Biol 29(1): 63-78.
28. Okino M, Mohri H. 1987. Effects of a high-voltage electrical impulse and an anticancer drug on in vivo growing tumors. Jpn J Cancer Res 78(12): 1319-1321.
29. Orlowski S, Belehradek J, Jr., Paoletti C, Mir LM. 1988. Transient electropermeabilization of cells in culture. Increase of the cytotoxicity of anticancer drugs. Biochem Pharmacol 37(24): 4727-4733.
30. Peacock EE, VanWinkle W. 1976. Biochemistry and environment of wounds. In: Peacock EE, VanWinkle W, editors. Wound repair. Philadelphia: Saunders, PA. p 154-160.
31. Peacock JL, Lawrence WT, Peacock EEJ. 1993. Wound healing. In: O'Leary PJ, Capote LR, editors. The physiologic basis of surgery. Baltimore, MD: Williams and Wilkins. p 95-99.
32. Peleg M. 2006. Advanced quantitative microbiology for foods and biosystems: Models for predicting growth and inactivation. Boca Raton, FL: CRC Taylor and Frances.
33. Polo M, Ko F, Busillo F, Cruse CW, Krizek TJ, Robson MC. 1997. The 1997 Moyer award. Cytokine production in patients with hypertrophic burn scars. J Burn Care Rehabil 18(6): 477-482.
34. Pucihar G, Krmelj J, Rebersek M, Napotnik T, Miklavcic D. 2011. Equivalent pulse parameters for electroporation. IEEE Trans Biomed Eng 58(11): 3279-3288.
35. Puliafito A, Hufnagel L, Neveu P, Streichan S, Sigal A, Fygenson DK, Shraiman BI. 2011. Collective and single cell behavior in epithelial contact inhibition. Proc Natl Acad Sci 109(3): 739-744.
36. Reiken S, Wolfort S, Berthiaume F, Compton C, Tompkins R, Yarmush M. 1997. Control of hypertrophic scar growth using selective photothermolysis. Lasers Surg Med 21: 7-12.
37. Robson MC. 2003. Proliferative scarring. Surg Clin North Am 83(3): 557-569.
38. Robson MC, Barnett RA, Leitch IOW, Hayward PG. 1992. Prevention and treatment of postburn scars and contracture. World Prog Surg 16(1): 87-96.
39. Robson MC, Steed DL, Franz MG. 2001. Wound healing: Biologic features and approaches to maximize healing trajectories. Curr Probl Surg 38(2): 72-140.
40. Rubinsky B. 2010. Irreversible electroporation. Berlin: Springer. p 314.
41. Sankaranarayanan K, Radhakrishnan S, Kanagaraj S, Rajendran R, Shahid S, Kathirvel P, Sundaresan V, Kumar Udayakumar V-K, Ramachandran R, Sundararajan R. 2011. Effect of irreversible electroporation on cell proliferation in fibroblasts. Proc ESA Ann Meeting Electrostatics 1-8.
42. Savage K, Swann DA. 1985. A Comparison of glycosaminoglycan synthesis by human fibroblasts from normal skin, normal scar, and hypertrophic scar. J Investig Dermatol 84(6): 521-526.
43. Seil JT, Webster TJ. 2007. Electrically active nanomaterials as improved neural tissue regeneration scaffolds. Wiley Interdiscip Rev Nanomed Nanobiotechnol 2(6): 635-647.
44. Shah M, Foreman DM, Ferguson MW. 1995. Neutralisation of TGF-beta 1 and TGF-beta 2 or exogenous addition of TGF-beta 3 to cutaneous rat wounds reduces scarring. J Cell Sci 108(3): 985-1002.
45. Sheridan RL, Tompkins RG. 2004. What's new in burns and metabolism. J Am Coll Surg 198(2): 243-263.
46. Singer AJ, Clark R. 1999. Mechanisms of disease: Cutaneous wound healing. N Engl J Med 341: 738-746.
47. Sonnemann KJ, Bement WM. 2011. Wound repair: Toward understanding and integration of single-cell and multicellular wound responses. Annu Rev Cell Dev Biol 27(1): 237-263.
48. Tan J, Peng X, Luo G, Ma B, Cao C, He W, Yuan S, Li S, Wilkins JA, Wu J. 2010. Investigating the Role of P311 in the hypertrophic scar. PLoS ONE 5(4): e9995.
49. Thomson KR, Cheung W, Ellis SJ, Federman D, Kavnoudias H, Loader-Oliver D, Roberts S, Evans P, Ball C, Haydon A. 2011. Investigation of the safety of irreversible electroporation in humans. J Vasc Intervent Radiol 22(5): 611-621.
50. Titomirov AV, Sukharev S, Kistanova E. 1991. In vivo electroporation and stable transformation of skin cells of newborn mice by plasmid DNA. Biochim Biophys Acta 1088(1): 131-134.
51. Vrbova G, Hudlicka O, Centofanti KS. 2008. Application of muscle/nerve stimulation in health and disease. Amsterdam: Springer. p 118.
52. Wang J, Dodd C, Shankowsky HA, Scott PG, Tredget EE. 2008. Deep dermal fibroblasts contribute to hypertrophic scarring. Lab Invest 88(12): 1278-1290.
53. Wasserman RJ, Polo M, Smith P, Wang X, Ko F, Robson M. 1998. Differential production of apoptosis-modulating proteins in patients with hypertrophic burn scar. J Surg Res 75: 74-80.
54. Weaver JC, Chimadzev YA. 1996. Theory of electroporation: A review. Bioelectrochem Bioenerg 41(2): 135-160.
55. Wolfort S, Reiken S, Berthiaume F, Tompkins R, Yarmush M. 1996. Control of hypertrophic scar growth using antibody targeted photolysis. J Surg Res 62: 17-22.
56. Zimmermann U. 1982. Electric field-mediated fusion and related electrical phenomena. Biochim Biophys Acta 694(3): 227-277.